GoPublic.AI Acquisition Corp. Fully Funded in Under 36 Hours!

GoPublic.AI is pleased to announce that it recently fully funded its Acquisition corp. within 36 hours. GoPublic has signed a Letter of Intent (“LOI”) with Forrest Innovations Ltd. to be 100% acquired by our acquisition Company, GoPublic.AI Acquisition Corp with the intent of listing on a major Canadian stock exchange this year.




As fellow investors, innovators, and change makers, we are honoured to have the individuals who participated to be a part of this with us. By supporting companies at these pivotal stages, your'e helping launch what could become world-changing companies. The team at GoPublic.AI will be working hard to ensure the transaction with Forrest goes according to plan in the most efficient and timely manner possible.


To keep those informed and educated, especially those unfamiliar in investing in an acquisition company, we've created a road map diagram for this transaction:

About Forrest Innovations:


Forrest is a private, Israel-based biotechnology company focused on the eradication of mosquito-borne diseases such as Dengue Fever and Zika using proprietary, ecologically safe, scalable and commercially approved technology. After 8 years of R&D, the company achieved a major milestone in 2020 as it began commercialization of their proprietary technology in Brazil and drove $500k in revenue. According to Forrest, they are now on track to do $2.8M in 2021, $7.4M in 2022, and $24.6M in 2023. The Founder/CEO previously built and sold a similar biotech company to Monsanto (now Bayer) for $125M. Highlights from Forrest:

  • Targeted valuation upon public listing: $20M-$25M

  • $3M invested by Founder/CEO

  • Commercially operating in Brazil

  • 48-56% profit margins

  • Proven proprietary technology


According to the Guardian, "More than 8 billion people could be at risk of malaria and dengue fever by 2080..." which makes mosquito-borne disease eradication an ever-increasing need.


Forrest reports that their proprietary technology, Natural Vector Control, is ecologically safe, scalable and commercially approved. Forrest's pilot and commercial projects in Brazil led to a 95% reduction in dengue fever in treated areas. For more information on Forrest, please check out their:

Website


If there is any further clarification needed, please feel free to reach out to Our Team of experts who will be happy to assist.